Childhood, adolescent and young adult cancer survivors treated with head or brain radiotherapy or cisplatin have an increased risk of hearing problems.
Because of this high risk survivors may benefit from surveillance for hearing loss.

Recommendations for surveillance for ototoxicity in survivors who were treated with platinum chemotherapy or radiotherapy to the brain or ear.
Childhood, adolescent and young adult cancer survivors treated with head or brain radiotherapy or cisplatin have an increased risk of hearing problems.
Because of this high risk survivors may benefit from surveillance for hearing loss.
Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.
Be the first to share your thoughts!

Separate fact from fiction with our guide to debunking common ovarian cancer myths. Learn the truth about symptoms, risk...

Trying to figure out what cancer screenings you should get is harder than it should be. Your doctor mentions a colonosco...

A friend forwarded me an email from her employer offering a blood test that, she was told, could "screen for over 50 can...